-transparent.png){kind=logo}
OK-432, a killed preparation of Streptococcus pyogenes, as well as Bacillus Calmette-Guerin (BCG) and Corynebacterium parvum are all known biological response modifiers. To examine the immunomodulatory effects of OK-432, natural killer cell activity and cytokine production by peripheral blood mononuclear cells (PBMCs) were assessed in 32 patients with gastric cancer. Skin tests for Streptococcus pyogenes A-3Su (Su-PS) and BCG were performed in all patients. Other nutritional and immunological parameters were also determined. OK-432-treated PBMCs showed a significant increase of cytotoxicity against K562 cells (p < 0.01). Increased levels of interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and interleukin-2 (IL-2) were found in the supernatants of cultures treated with OK-432 in 29 (90.6%), 20 (62.5%), and 8 (25.0%) out of 32 patients, respectively. Natural killer cell activity, IFN-gamma production, and the Su-PS skin test were positively correlated (p < 0.01). In contrast, the BCG test and other markers were not correlated with natural killer cell activity and IFN-gamma production. These results suggest that the Su-PS skin test could predict OK-432-induced natural killer cell activity and IFN-gamma production in patients with gastric cancer, and was therefore useful to determine whether patients were responders to OK-432.
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
October 1992,
Rinsho byori. The Japanese journal of clinical pathology,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
January 1992,
Journal of clinical & laboratory immunology,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
June 1987,
Nihon Geka Gakkai zasshi,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
June 1991,
Nihon Sanka Fujinka Gakkai zasshi,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
August 2001,
Neurologia medico-chirurgica,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
December 1982,
The Keio journal of medicine,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
April 1982,
Nihon Gan Chiryo Gakkai shi,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
July 1981,
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
May 1992,
Journal of immunotherapy : official journal of the Society for Biological Therapy,
F Nakayama, and
H Iwagaki, and
A Gouchi, and
A Hizuta, and
H Isozaki, and
N Takakura, and
N Tanaka
April 1989,
Nihon Gan Chiryo Gakkai shi,
